Hep B and C Pharmacology

  1. What is the treatment goal for Hepatitis B (HBV)?
    Reduce HBV DNA to undetectable levels
  2. True/false: HBV can be eradicated
    False; it cannot, that’s why the goal isn’t to clear out the virus, but just to reduce the DNA level
  3. MOA and route of admin of antiviral agents for Hep B:
    • Inhibit HBV polymerase
    • Oral
  4. Nucleotide/nucleoside analog agents:
    • Lamivudine
    • Entecavir
    • Tenofovir
    • (these are used for HBV because HBV has DNA)
  5. Which HBV nucleotide analog can the virus become resistant to?
    Lamivudine
  6. Which HBV nucleotide analog also has therapeutic effect for HIV?
    • Lamivudine
    • tenofovir
  7. True/false: HBV resistance often seen with entecavir use
    False; it’s lamivudine
  8. Which HBV nucleotide analog can cause GI complaints and rash?
    Tenofovir
  9. What is the MOA of interferon alfa?
    • Stimulate interferon receptors, works through JAK STAT
    • Interferon helps prepare uninfected cells from virus
  10. What is a drug that’s indicated for both HBV and Hep C?
    • Peg interferon alfa 2a/b
    • Administered Subcutaneous or IM
  11. What are ADR for peg interferon alfa 2/ab
    • Flu-like syndrome
    • Neurotoxicity
    • Myalgias
    • Bone marrow suppression
  12. What is a main contraindication for peg interferon use?
    Pregnancy
  13. Which hepatitis drug must you reduce the dosage for patients with renal insufficiency?
    Peg interferon alfa 2a/b
  14. True/false: goal of treatment for HCV is to reduce the viral load
    False; goal for HCV is to cure/ eradication
  15. Patient with chronic Hep C is at risk for developing which disease?
    Cirrhosis
  16. What are agents used to treat HCV?
    • Peg interferon alfa
    • Ribavirin
    • Simpeprevir, sofosbuvir, Harvoni (these are the new direct acting antiviral agents)
  17. Which hepatitis drug is a guanosine analog?
    Ribavirin (used to treat HCV)
  18. What is the MOA of ribavirin?
    • Interfere with GTP synthesis
    • Inhibit capping of viral mRNA
    • Inhibit RNA polymerase
  19. True/false: Ribavirin can also be used in treatment for influenza, RSV and HIV, in addition to HCV
    True
  20. Pregnant patients should avoid which hepatitis drugs?
    • Peg interferon
    • Ribavirin
  21. Which hepatitis C drug can cause hemolytic anemia?
    Ribavirin
  22. Which drug has embryocidal and teratogenic effects and should wait 6 months after use before thinking about getting pregnant?
    Ribavirin (for HCV)
  23. Direct-acting antiviral (DAA) agents:
    • Simeprevir
    • Sofosbuvir
    • Ledipasvir
    • Harvoni (sofobuvir + ledipasvir)
  24. DAA that inhibit NS3 protease have _______ stem. NS5A protease inhibitor has ________ stem. And NS5B inhibitor has _______.
    • -Previr
    • -Asvir
    • -Buvir
  25. What is the black box warning for Direct acting antivirals?
    Can reactivate HBV, so must screen HCV patients for HCB before putting them on DAAs
  26. Simeprevir MOA:
    Inhibit HCV NS3/4A serine protease
  27. Which DAA for HCV has drug interaction by modifying activity of CYP3A4?
    Simeprevir
  28. Which DAA drug should not be used with statin? What can it be used with?
    • Simeprevir should not be used with Statins,
    • But can be used in combination with PEG INF, ribavirin or sofosbuvir
  29. Sofosbuvir can be used in combination with which drugs:
    Simeprevir, ribavirin, or ribavirin + PEG INF
  30. Must check for negative pregnancy test before initiation of this DAA drug____:
    sofosbuvir
  31. MOA of Sofosbuvir:
    Inhibits HCV NS5B
  32. Harvoni is combination of ______ and ____
    Sofosbuvir and ledipasvir
Author
lykthrnn
ID
347183
Card Set
Hep B and C Pharmacology
Description
GI Final- Pharmacology
Updated